Page 96 - Read Online
P. 96

expression of the cell cycle-dependent kinase inhibitor   breast cancer prognostic marker by global gene expression
               p27(Kip1). Oncogene 2006;25:1391-9.                meta-analysis. Cancer Res 2005;65:11259-64.
            17.  Wolf I, Bose S,  Williamson EA, Miller CW, Karlan BY,   24.  Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ,
               Koeffl er HP. FOXA1: growth inhibitor and a favorable   Eeckhoute J, Shao  W, Hestermann EV, Geistlinger  TR,
               prognostic factor in human breast cancer.  Int J Cancer   Fox EA, Silver PA, Brown M. Chromosome-wide mapping
               2007;120:1013-22.                                  of estrogen receptor binding reveals long-range regulation
            18.  Ho IC, Vorhees P, Marin N, Oakley BK, Tsai SF, Orkin SH,   requiring the forkhead protein FoxA1. Cell 2005;122:33-43.
               Leiden JM. Human GATA3: a lineage-restricted transcription   25.  Carroll JS, Brown M. Estrogen receptor target gene: an
               factor that regulates the expression of the T cell receptor gene.   evolving concept. Mol Endocrinol 2006;20:1707-14.
               EMBO J 1991;10:1187-92.                        26.  Laganiere J, Deblois G, Lefebvre C, Bataille  AR, Robert F,
            19.  Hoch RV,  Thompson DA, Baker RJ,  Weigel RJ. GATA-3 is   Giguère V. From the Cover: Location analysis of estrogen receptor
               expressed in association with estrogen receptor in breast   alpha target promoters reveals that FOXA1 defi nes a domain of the
               cancer. Int J Cancer 1999;84:122-8.                estrogen response. Proc Natl Acad Sci U S A 2005;102:11651-6.
            20.  Kouros-Mehr H, Slorach EM, Sternlicht MD,  Werb Z.   27.  Nakshatri H, Badve S. FOXA1 in breast cancer.  Expert Rev
               GATA-3 maintains the differentiation of the luminal cell fate   Mol Med 2009;11:e8.
               in the mammary gland. Cell 2006;127:1041-55.   28.  Keeple J, Henry-Tillman RS, Klimberg  VS, Layeeque R,
            21.  Kouros-Mehr H, Kim JW, Bechis SK,  Werb Z. GATA-3 and   Siegel E, Westbrook K, Korourian S. The receptor expression
               the regulation of the mammary luminal cell fate.  Curr Opin   pattern in ductal carcinoma in situ  predicts recurrence.  Am J
               Cell Biol 2008;20:164-70.                          Surg 2006;192:68-71.
            22.  Jacquemier J, Charafe-Jauffret E, Monville F, Esterni B,
               Extra JM, Houvenaeghel G, Xerri L, Bertucci F, Birnbaum D.   How to cite this article: Chivukula M, Picarsic J, Bulusu G, Brufsky A,
               Association of GATA3, P53, Ki67 status and vascular   Ahrendt G, Carter G. Prognostic signifi cance of transcription factors
               peritumoral invasion are strongly prognostic in luminal breast   FOXA1 and GATA-3 in ductal carcinoma in situ in terms of recurrence
                                                               and estrogen receptor status. J Cancer Metastasis Treat 2015;1:84-9.
               cancer. Breast Cancer Res 2009;11:R23.
            23.  Mehra R, Varambally S, Ding L, Shen R, Sabel MS, Ghosh D,   Received: 18-12-2014; Accepted: 21-04-2015.
               Chinnaiyan  AM, Kleer CG. Identifi cation of GATA3 as a   Source of Support: Nil, Confl ict of Interest: None declared.




















































                Journal of Cancer Metastasis and Treatment  ¦  Volume 1 ¦ Issue 2 ¦ July 15, 2015 ¦        89
   91   92   93   94   95   96   97   98   99   100   101